• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Hum Genet . Genetic determinants of IgG antibody response to COVID-19 vaccination

tetano

Editor, Senior Moderator
Am J Hum Genet


. 2024 Jan 4;111(1):181-199.
doi: 10.1016/j.ajhg.2023.12.005. Genetic determinants of IgG antibody response to COVID-19 vaccination

Shengzhe Bian[SUP] 1 [/SUP], Xinxin Guo[SUP] 1 [/SUP], Xilai Yang[SUP] 1 [/SUP], Yuandan Wei[SUP] 1 [/SUP], Zijing Yang[SUP] 1 [/SUP], Shiyao Cheng[SUP] 1 [/SUP], Jiaqi Yan[SUP] 1 [/SUP], Yongkun Chen[SUP] 1 [/SUP], Guo-Bo Chen[SUP] 2 [/SUP], Xiangjun Du[SUP] 3 [/SUP], Stephen S Francis[SUP] 4 [/SUP], Yuelong Shu[SUP] 5 [/SUP], Siyang Liu[SUP] 6 [/SUP]



Affiliations
Abstract

Human humoral immune responses to SARS-CoV-2 vaccines exhibit substantial inter-individual variability and have been linked to vaccine efficacy. To elucidate the underlying mechanism behind this variability, we conducted a genome-wide association study (GWAS) on the anti-spike IgG serostatus of UK Biobank participants who were previously uninfected by SARS-CoV-2 and had received either the first dose (n = 54,066) or the second dose (n = 46,232) of COVID-19 vaccines. Our analysis revealed significant genome-wide associations between the IgG antibody serostatus following the initial vaccine and human leukocyte antigen (HLA) class II alleles. Specifically, the HLA-DRB1[SUP]∗[/SUP]13:02 allele (MAF = 4.0%, OR = 0.75, p = 2.34e-16) demonstrated the most statistically significant protective effect against IgG seronegativity. This protective effect was driven by an alteration from arginine (Arg) to glutamic acid (Glu) at position 71 on HLA-DRβ1 (p = 1.88e-25), leading to a change in the electrostatic potential of pocket 4 of the peptide binding groove. Notably, the impact of HLA alleles on IgG responses was cell type specific, and we observed a shared genetic predisposition between IgG status and susceptibility/severity of COVID-19. These results were replicated within independent cohorts where IgG serostatus was assayed by two different antibody serology tests. Our findings provide insights into the biological mechanism underlying individual variation in responses to COVID-19 vaccines and highlight the need to consider the influence of constitutive genetics when designing vaccination strategies for optimizing protection and control of infectious disease across diverse populations.

Keywords: COVID-19; IgG response to vaccines; cross-ancestry; electrostatic potential energy; fine-mapping; genome-wide association study; human leukocyte antigen; transcriptome-wide association study.

 
Back
Top Bottom